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Abstract  
Background: Pyoderma gangrenosum (PG) is a rare neutrophil-mediated autoinflammatory dermatosis, 
which may involve the oral mucosa. Dental surgery represents a potential triggering factor for the onset of 
PG lesions. Here, we describe and discuss the dental management of a rare case of aggressive periodontitis 
in a PG patient, from multiple tooth extractions to prosthetic rehabilitation, including systemic steroid 
prophylaxis administration before surgery to prevent the potential onset of PG-related lesions. Case report: 
A 22-years-old male patient previously diagnosed with PG and affected by aggressive periodontal disease, 
underwent dental extractions, gingivoplastic surgery and prosthetic rehabilitation. The patient was pre-
medicated with 8 mg intramuscular betamethasone 20 minutes before the oral surgical procedure. The 
tissues healed perfectly and no adverse effects were reported. Practical implications: In case of minor oral 
surgery, prophylactic corticosteroids might help to reduce the risks of PG-related lesions. The prosthetic 
devices should be planned in order to be as atraumatic as possible. 
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Introduction 
Firstly reported in 1930 by Brunsting, pyoderma gangrenosum (PG) is to date regarded as a neutrophil-
mediated autoinflammatory dermatosis 1,2. PG is a rare skin disease with an incidence varying from 3 to 10 
patients per million 3, which may affect individuals at any age with a peak at 20-50 years and with a slight 
predisposition for females 3,4. PG involvement of the oral cavity is even more rare, with just few cases 
reported in literature 5. In about half of the cases, a systemic disease associated with PG can be identified: 
more often, inflammatory bowel diseases, endocrine diseases, rheumatoid arthritis and hematological 
disorders 2,4. Otherwise, PG can be idiopathic or can contribute to define rare syndromes, such as PAPA 
syndrome (Pyogenic Arthritis, Pyoderma gangrenosum and Acne). 
The typical PG signs are sterile cutaneous pustules, in most cases localized at the legs, characterized by a 
neutrophilic granulocytes’ infiltrate 6. In the ulcerating PG subtype, pustules result in very painful ulcers 
with undermined purple borders and a central area of necrosis exuding pus, while in the vegetating PG 
subtype, the same pustules result in vegetating erosions 6. Pustular forms of PG, either as bullous lesions 
(“bullous PG”) or as multiple pustules (“pustular PG”), are sporadic 6. Further extracutaneous lesions can 
involve the subcutaneous adipose tissue in form of panniculitis and the eye with corneal ulceration. 
Internal organs, such as bone or lungs, are rarely affected 6. Infrequently, intraoral and lip ulcers have been 
also described in PG patients 5–7.  
The diagnosis requires the presence of both the two major criteria (presence of clinical lesions and 
exclusion of other possible causative diseases, basing on medical history and clinical findings) and, at least, 
two additional criteria, which include microbiology testing and histological examinations, particularly 
pivotal for differential diagnosis 6. Histology contributes to exclude other diseases rather than to confirm 
the diagnosis, as only 7% of the biopsies were reported to show specific features, such as neutrophilic 
infiltration of the dermis, signs of vasculitis and accumulation of immunoglobulins and/or complement 
factors beside the vessels 6,8. Currently, the PG standard treatment consists of systemic steroids 
administration, although, in presence of resistant cases, dapsone represents an alternative therapy 6,8. 
Topical steroids are particularly useful to manage oral ulcers 9. 
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Most patients report a triggering factor that initiated or worsened the disease. Indeed, the phenomenon of 
pathergy, which correlates to an abnormal response to stimuli such as mechanical traumas (surgery, stings, 
or bites), is a typical findings in PG 6,10. When surgery is required, evidence suggests that a corticosteroid-
based prophylaxis could reduce the risk of PG-related lesions triggered by surgical trauma 11,12, although no 
specific guidelines for PG patients receiving dental surgery are available to date. In 2007, a clinical case 
reported the onset of a PG lesion of the maxillary sinus following tooth extraction. The authors concluded 
that prophylactic corticosteroid could be of help in case of surgical interventions 12. A further 
recommendation was recently reported by Bissonnette et al. 7 who stated that “surgical debridement of PG 
lesion should be avoided without concomitant medically-induced immunosuppression or pre-operative 
corticosteroids as surgery has been demonstrated to exacerbate cutaneous PG”. 
Given the rarity of this disease and the current limited availability of established guidelines for oral surgical 
procedures, this clinical case aims at reporting the dental management of a case of aggressive periodontal 
disease in a young patient with a previous diagnosis of PG, who required multiple dental extractions and 
gingivoplastic surgery and who was not under concurrent immunosuppressive therapy at the time of dental 
surgery. The surgical treatment was performed following intramuscular corticosteroid prophylaxis to 
reduce the potential risk of triggering PG-associated oral lesions. The subsequent prosthetic oral 
rehabilitation is also described, resulting altogether in a clinically successful outcome. 
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Case report  
 
In October 2015, a 22-years-old male patient was referred by his general practitioner to our clinic (Clinica 
Odontoiatrica ASST Santi Paolo e Carlo, Università degli Studi di Milano) for periodontal evaluation. The 
patient was affected by hepatitis B and, three years before, received a diagnosis of cutaneous PG. Since 
then, he had a history of intermittent systemic steroid treatment based on the use of dexamethasone and 
dapsone. When he came to our clinic, he was under dapsone, further suspended by his specialist a few 
weeks later. 
At the oral examination, the patient was partially edentulous, with few remaining, hopeless teeth 
characterized by grade III mobility (Miller Classification), severe gingival inflammation and bleeding on 
gentle probing. The patient had a very poor oral hygiene compliance and reported severe pain at tooth 
brushing (Figure 1 a). The panoramic radiograph showed severe loss of alveolar bone, consistent with the 
clinical picture (Figure 1 b). 
The following treatment plan was formulated: extraction of all the remaining teeth in two stages (upper 
jaw and, subsequently, lower jaw) and the delayed fabrication of upper and lower total dentures. 
At the time of dental extraction, the patient, who was not receiving any systemic treatment for PG since a 
few weeks, was pre-medicated with 8 mg intramuscular betamethasone 20 minutes before surgery. After a 
mouthwash with 0.2% gluconate chlorhexidine right before the intervention, local anesthesia was obtained 
by injecting mepivacaine 2% plus epinefrine 1:100.000. All teeth were extracted without the need of 
opening flaps or performing osteotomy. A first intention suture was achieved with silk. The patient received 
post-surgical instructions and was prompted to rinse with 0.2% gluconate chlorhexidine twice a day for 2 
weeks and apply 1% chlorhexidine gel three times a day for two weeks on the wounds. The extracted teeth 
were preserved in 10% formalin for histological analysis. The sutures were removed one week after surgery 
and complete healing of the soft tissues was observed (Figure 2 a, b and c). At weekly follow-up visits, the 
patient did not complain of any peculiar pain or discomfort. 
One month following the lower jaw extractions, the soft tissues appeared to have perfectly healed but, in 
the third quadrant, gingival remodeling resulted in a mucosal flap that would have hindered the correct 
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fabrication of the lower jaw denture. Therefore, gingivoplastic surgery of the affected area was performed 
(Figures 3 a and b) following the same pre-medication protocol with intramuscular betamethasone. First 
intention closure was achieved by means of a Vycril® 5/0 suture (Ethicon Inc, Somerville, New Jersey, US) 
(Figures 3 c) The patient was provided with the same post-surgical instructions as for tooth extractions. The 
removed gingiva was preserved in 4% formalin solution for histological analysis. Two weeks later, at suture 
removal, a small ulceration was observed at the site of a stitch. The lesion was treated with 1% 
chlorhexidine gel (Corsodyl®, GlaxoSmithKline plc, London, UK) application three times a day for two weeks 
on the wound and completely resolved in 3 weeks (Figure 3 d). The patient was therefore deemed ready to 
start the prosthetic phase. 
Alginate impressions were obtained and custom-made impression trays fabricated. Definitive impressions 
were taken one week later with a polysulfide impression material (Permlastic Regular®, Kerr Italia srl, 
Scafati, Salerno, Italy). Two weeks later, the teeth mounted on a wax rim were tested and their fit was 
adjusted on the patient. After two more weeks, the dentures were finalized and delivered to the patient 
who expressed his great satisfaction. 
In the next 3 months, follow-up visits were performed every two weeks, during which the base of the 
dentures was adjusted when required. The oral mucosa was carefully examined at each visit in order to 
detect potential traumatic lesions. At 3 months, a painful traumatic ulceration occurred in the inferior jaw, 
localized at the anterior left fornix. The denture base was corrected and the patient was instructed to apply 
1% chlorhexidine gel three times a day for two weeks on the wound. Two weeks later, at control, the 
ulceration had fully resolved. At two-years follow up, the patient showed a healthy mucosa and a complete 
congruence of the dentures (Figures 4 a, b, c and d).  
Dental histological examination, performed after tooth processing for ground sectioning 13 and further 
staining with Toluidine Blue and Pyronin Yellow revealed a normal architecture of both enamel and dentine 
(Figure 5 a and b), beyond areas of demineralization and carious lesions concerning some teeth. On the 
coronal portion of the root, calculus was evident. When visible, the periodontal ligament, lining the apical 
portion of the root, did not show any inflammatory cells infiltration (Figure 5 c). The histological 
examination of the gingival tissue, performed after including the soft tissue biopsies in paraffin and staining 
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the sections with Hematoxylin & Eosin, showed a dense, mixed inflammatory infiltrate with a large 
prevalence of neutrophils and lymphocytes (Figures 5 d).  
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Discussion 
The present case-report describes the management of a patient affected by PG and aggressive periodontal 
disease, requiring multiple extractions and prosthetic rehabilitation. Few reports exist concerning the oral 
manifestations of PG, that can be considered a very rare clinical finding (for review see Curi et al. 9 and 
Bissonnette et al. 7). Hernandez-Hernández-Martín et al. reported the case of a 84-years-old woman 
presenting a PG oral ulcer 14 not associated with skin lesions, which resolved a few weeks later by 
treatment with oral steroids. A case of oral involvement related to PG was reported in a 65 years old 
woman with skin lesions and a deep ulceration of the tongue and it was successfully treated with 
mycophenolate mofetil. 15 Irregular, painful, large oral lesions in patients with PG have been reported to 
involve tongue, palate, lips, buccal mucosa, gingiva and tonsils 4,16–20. Concerning the involvement of 
periodontal tissues, Paramkusam et al. 5 reported of a 42-years old woman with a dermatologic diagnosis 
of PG and under treatment with corticosteroids, dapsone, cyclosporine, and metrogyl DG gel, who 
presented skin lesions and a solitary ulcer localized at the right anterior hard palate. The latter was 
associated with the presence of severe periodontal lesions of the upper anterior teeth (1.2 and 1.3), which 
showed grade III mobility. 5 The patient underwent tooth extraction of 1.2 and 1.3 and was instructed to 
apply metronidazole ointment three times a day over the lesion and to rinse using a chlorhexidine-based 
mouthwash three times a day, besides taking systemic prednisolone and dapsone 5. After 2 weeks, a new 
ulcer appeared on the left retromolar area, which healed, together with the palatal lesion, 6 weeks later. 5 
Marzano et al. reported of a case of severe periodontal disease in an 18-year-old Pakistani man affected by 
PG, consisting in loss of bone support of most of his teeth and jaws atrophy 1. In the previous and the 
present cases, however, a conclusive dissertation is not possible whether the aggressive periodontal 
disease is a manifestation or a consequence of PG rather than an independent and concomitant condition. 
Nonetheless, despite PG oral involvement is an uncommon finding 5, dental practitioners are asked to 
recognize and manage such patients and, when required, to perform accurate periodontal treatments, 
dental extractions and oral rehabilitations. The rarity of PG largely hindered the development of guidelines 
for performing oral surgical procedures in these patients, to date still anecdotal. Since surgery has been 
identified as triggering factor for PG lesions due to pathergy, when a surgical intervention becomes 
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necessary, currently available evidence (mainly related to non-oral and extensive surgeries) suggests that a 
steroid treatment, in form of concomitant medically induced immunosuppression or pre-operative 
corticosteroids, be used 12,21,22. A recent systematic review of post-surgical PG referring to breast, cardio-
thoracic, or abdominal surgeries concluded that a careful follow-up of wound healing is needed, and, in 
case of breast surgery, perioperative prednisone may prevent PG-related lesions at the surgical site 22. 
Although specific guidelines do not exist for oral surgery in PG patients, it seems reasonable to adopt the 
same standards. Tallon and co-workers described a maxillary sinus PG lesion developed following tooth 
extraction in a patient and suggested that prophylactic corticosteroid for essential surgical interventions 
should be used 12. Such suggestion is consistent with most clinical reports on minor oral surgery (like oral 
biopsies or tooth extractions) in patients with PG 11. In the case report by Paramkusam et al. 5, the authors 
opted for a medication with prednisolone and dapsone soon after tooth extractions. In other studies 14,23, 
at the time of mucosal biopsy, the patients were already under steroid treatment for their systemic 
condition. In a further case where patient had PG-like lesions requiring oral biopsy 9, but no specific 
intervention was detailed.  
Basing on the existing literature 11,12,22 and in absence of established guidelines for oral surgical procedures, 
the current clinical case was managed by administrating a steroid-based prophylaxis consisting in 
intramuscular betamethasone before oral surgery to prevent potential post-surgical PG lesions, under the 
rationale that PG is an autoinflammatory dermatosis that can be triggered by surgical trauma and that it is 
responsive to steroid therapy. The risk of developing PG lesions following surgery has been documented in 
the literature and, consistently, as mentioned above, the available knowledge supports the use of peri-
operative steroid therapy when surgical interventions are needed in these patients 11,12,22. Biologically, 
indeed, glucocorticoids induce anti-inflammatory and immunosuppressive effects, by interfering with key 
inflammatory pathways (NF-κB and AP-1) 24 and, particularly, by inhibiting neutrophil activation, 
chemotaxis, adhesion, transmigration, apoptosis, oxidative burst, and phagocytosis 25. Moreover, primary 
intention wound closure was obtained and topical application of antiseptic agent (chlorhexidine) prescribed 
to prevent wound infection. Such protocol resulted, in our case, in successful healing and lack of 
complications, thus supporting the usefulness of prophylactic corticosteroids used to decrease the risks of 
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PG-related lesions before oral surgery, when the patient is not already under concurrent 
immunosuppressive therapy, as already suggested by Tallon et al. 12. Nonetheless, the prosthetic 
rehabilitation was carefully followed-up on a long-term basis, in order to detect potential lesions or trauma. 
The histological findings showed the presence of a large number of neutrophils and lymphocytes within the 
gingival soft tissues, a typical finding in periodontal diseases. From a histological point of view, it is not 
possible to differentiate among chronic and aggressive periodontitis, as both forms share similar 
histological features, i.e. an inflammatory infiltrate characterized by neutrophils, lymphocytes and plasma 
cells. Over the time, inflammation results in different degrees of periodontal destruction with variable 
clinical outcomes (from pathological periodontal pockets to tooth mobility and, eventually, tooth loss), 
based on a still not well-defined individual susceptibility of the host. The intraoral clinical condition of our 
patient, together with the soft tissue histological findings, the young age and the severity of periodontal 
destruction, support the diagnosis of an aggressive form of periodontal disease. The latter might have been 
sustained by the systemic condition of the patient, although conclusive dissertations about a correlation 
between PG and aggressive periodontitis remain under debate. 
Future directions for dental practitioners cannot be exempted from including an accurate and periodical 
oral examination of PG patients, aiming at excluding both mucosal lesions and/or periodontal diseases, 
whose outcomes would greatly benefit by early diagnosis and treatment. In particular, a well planned 
periodontal supportive therapy to prevent oral diseases acquires, in these patients, overwhelming 
importance, in the perspective of preserving oral health, reducing the number of diseased teeth and the 
need of tooth extraction at a young age (as it occurred in our case) and, globally, maintaining a patient’s 
satisfactory quality of life.  
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Conclusions 
Dentists should be aware of the potential oral involvement of PG in forms of mucosal ulcers and/or 
periodontal disease. Dental treatment is not exempted from risks; especially dental surgery may represent 
a potential triggering factor for PG lesions. As in our case, when minor oral surgery, in particular, is 
required, prophylactic corticosteroids may be of help to decrease the risks of PG-related lesions, especially 
when the patient is not already under immunosuppressive therapy. Nonetheless, follow-up visits are 
pivotal, in order to check carefully the post-surgical mucosal healing, the congruence of prosthetic 
rehabilitation and to intercept potentially early lesions. 
Future research, including clinical trial on larger population, should focus on better elucidate the efficacy of 
this approach in preventing lesions’ occurrence. 
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Figure legends 
Figure 1. Patient’s oral condition of aggressive periodontal disease. Clinical image (a) and panoramic 
radiograph (b) at baseline. 
Figure 2. Healing of tissues after dental extraction: frontal view (a) and occlusal views of upper (b) and 
lower (c) dental arches. 
Figure 3. Pre-prosthetic surgery at III dental quadrant. Clinical pictures of gingival flange before 
intervention (a); gingivoplastic surgery with gingival tissue removal (b) and first intention suture (c); healing 
of soft tissue after surgery (c). 
Figure 4. Prosthetic oral rehabilitation (two-year follow up). Total upper and lower dentures after 
finalization (a and b, respectively), and the patient wearing the prostheses (c and d).  
Figure 5. Histological aspect of the hard and soft tissues. Enamel and dentine structure were preserved 
(a); figure (b) highlights the typical dentinal tubules. Periodontal ligament showed the absence of 
inflammatory infiltrate (c), which was detectable within the gingival tissue, instead (d). Toluidine Blue and 
Pyronin Yellow staining (a, b, c), Hematoxylin and Eosin staining (d).  
